678
Views
20
CrossRef citations to date
0
Altmetric
Original Research

Impact of the Transition from ICD–9–CM to ICD–10–CM on the Identification of Pregnancy Episodes in US Health Insurance Claims Data

ORCID Icon, , , , & ORCID Icon
Pages 1129-1138 | Published online: 15 Oct 2020

References

  • Platt R, Carnahan RM, Brown JS, et al. The U.S. Food and Drug Administration’s Mini-Sentinel program: status and direction. Pharmacoepidemiol Drug Saf. 2012;21(Suppl 1):1–8.
  • Franklin JM, Glynn RJ, Martin D, Schneeweiss S. Evaluating the use of nonrandomized real-world data analyses for regulatory decision making. Clin Pharmacol Ther. 2019;105(4):867–877. doi:10.1002/cpt.135130636285
  • Huybrechts KF, Bateman BT, Hernandez-Diaz S. Use of real-world evidence from healthcare utilization data to evaluate drug safety during pregnancy. Pharmacoepidemiol Drug Saf. 2019;28(7):906–922. doi:10.1002/pds.478931074570
  • MacDonald SC, Cohen JM, Panchaud A, McElrath TF, Huybrechts KF, Hernandez-Diaz S. Identifying pregnancies in insurance claims data: methods and application to retinoid teratogenic surveillance. Pharmacoepidemiol Drug Saf. 2019;28(9):1211–1221.31328328
  • Matcho A, Ryan P, Fife D, Gifkins D, Knoll C, Friedman A. Inferring pregnancy episodes and outcomes within a network of observational databases. PLoS One. 2018;13(2):e0192033. doi:10.1371/journal.pone.019203329389968
  • Andrade SE, Toh S, Houstoun M, et al. Surveillance of medication use during pregnancy in the mini-sentinel program. Matern Child Health J. 2016;20(4):895–903. doi:10.1007/s10995-015-1878-826645616
  • Margulis AV, Setoguchi S, Mittleman MA, Glynn RJ, Dormuth CR, Hernandez-Diaz S. Algorithms to estimate the beginning of pregnancy in administrative databases. Pharmacoepidemiol Drug Saf. 2013;22(1):16–24. doi:10.1002/pds.328422550030
  • Palmsten K, Huybrechts KF, Mogun H, et al. Harnessing the Medicaid Analytic eXtract (MAX) to evaluate medications in pregnancy: design considerations. PLoS One. 2013;8(6):e67405. doi:10.1371/journal.pone.006740523840692
  • Li Q, Andrade SE, Cooper WO, et al. Validation of an algorithm to estimate gestational age in electronic health plan databases. Pharmacoepidemiol Drug Saf. 2013;22(5):524–532. doi:10.1002/pds.340723335117
  • Hornbrook MC, Whitlock EP, Berg CJ, et al. Development of an algorithm to identify pregnancy episodes in an integrated health care delivery system. Health Serv Res. 2007;42(2):908–927. doi:10.1111/j.1475-6773.2006.00635.x17362224
  • Toh S, Mitchell AA, Werler MM, Hernandez-Diaz S. Sensitivity and specificity of computerized algorithms to classify gestational periods in the absence of information on date of conception. Am J Epidemiol. 2008;167(6):633–640.18194999
  • Zhu Y, Hampp C, Wang X, et al. Validation of algorithms to estimate gestational age at birth in the Medicaid Analytic eXtract-Quantifying the misclassification of maternal drug exposure during pregnancy. Pharmacoepidemiol Drug Saf. 2020. doi:10.1002/pds.5126..
  • Mainor AJ, Morden NE, Smith J, Tomlin S, Skinner J. ICD-10 coding will challenge researchers: caution and collaboration may reduce measurement error and improve comparability over time. Med Care. 2019;57(7):e42–e46. doi:10.1097/MLR.000000000000101030489544
  • Panozzo CA, Woodworth TS, Welch EC, et al. Early impact of the ICD-10-CM transition on selected health outcomes in 13 electronic health care databases in the United States. Pharmacoepidemiol Drug Saf. 2018;27(8):839–847. doi:10.1002/pds.456329947033
  • Chabra S. International classification of diseases, 10th Revision, coding for prematurity: need for standardized nomenclature. Health Care Manag (Frederick). 2015;34(2):123–127. doi:10.1097/HCM.000000000000005325909399
  • Panozzo CA, Welch EC, Woodworth TS, et al. Assessing the impact of the new ICD-10-CM coding system on pharmacoepidemiologic studies-an application to the known association between angiotensin-converting enzyme inhibitors and angioedema. Pharmacoepidemiol Drug Saf. 2018;27(8):829–838. doi:10.1002/pds.455029947045
  • Heslin KC, Owens PL, Karaca Z, Barrett ML, Moore BJ, Elixhauser A. Trends in opioid-related inpatient stays shifted after the US transitioned to ICD-10-CM diagnosis coding in 2015. Med Care. 2017;55(11):918–923. doi:10.1097/MLR.000000000000080528930890
  • Initiative S, ed.Use of Multiple Sclerosis Drugs Among Pregnant Women. 2018.
  • Hernandez-Diaz S, Huybrechts KF, Desai RJ, et al. Topiramate use early in pregnancy and the risk of oral clefts: a pregnancy cohort study. Neurology. 2018;90(4):e342–e351. doi:10.1212/WNL.000000000000485729282333
  • Huybrechts KF, Hernandez-Diaz S, Straub L, et al. Association of maternal first-trimester ondansetron use with cardiac malformations and oral clefts in offspring. JAMA. 2018;320(23):2429–2437.30561479
  • Sarayani A, Albogami Y, Elkhider M, Hincapie-Castillo JM, Brumback BA, Winterstein AG. Comparative effectiveness of risk mitigation strategies to prevent fetal exposure to mycophenolate. BMJ Qual Saf. 2019.
  • Shin J, Cheetham TC, Wong L, et al. The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system. J Am Acad Dermatol. 2011;65(6):1117–1125. doi:10.1016/j.jaad.2010.09.01721565419
  • Martin JA, Hamilton BE, Osterman MJK. Births in the United States, 2018. NCHS Data Brief. 2019;(346):1–8.